medigraphic.com
SPANISH

Revista de Nefrología, Diálisis y Trasplante

ISSN 0326-3428 (Print)
Órgano de difusión científica de la Asociación Nefrológica de Buenos Aires
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2025, Number 4

<< Back Next >>

Rev Nefrol Dial Traspl 2025; 45 (4)

Iron parameters in kidney transplant recipients and their effects on graft functions

Ergun G, Kasapoglu U
Full text How to cite this article

Language: English
References: 21
Page: 188-194
PDF size: 235.01 Kb.


Key words:

ferritin, transferrin saturation, kidney transplantation, anemia.

ABSTRACT

Background: Anemia is more common in renal transplant recipients than in those with chronic kidney disease (CKD) who have a similar glomerular filtration rate (GFR). Iron deficiency is the most common factor contributing to early post-transplant anemia (PTA). Several factors lead to iron deficiency, including inadequate iron stores at the time of transplantation, blood loss during surgery, increased iron utilization due to the onset of erythropoiesis, and poor nutrition. In this study, we aimed to investigate the effects of iron parameters and graft function in renal transplant recipients. Methods: All patients who underwent renal transplantation in Bakirkoy Dr. Sadi Konuk Education and Research Hospital Nephrology Department between January 2016 and January 2019 were analyzed retrospectively. Data on age, sex, primary disease at the time of transplantation were notted. Hemoglobin, ferritin, and transferrin saturation were recorded before and after transplantation. The effects of these parameters on graft function were examined. Results: There was no statistically significant difference in the prognosis results according to the preop Ferritin values. The postop 1st year Ferritin values of the patients with poor prognosis were statistically significantly higher than the patients with good prognosis. Preoperative saturation values of patients with poor prognosis were statistically significantly higher than those with good prognosis. Prognosis results did not show a statistically significant difference according to preop, postop 1st year and 2nd year haemoglobin values. Conclusions: In conclusion, while ferritin level and transferrin saturation negatively affected the prognosis in renal transplant recipients, hemoglobin level did not affect the prognosis. More extensive and prospective studies are needed on this subject.


REFERENCES

  1. Johansen, Kirsten L, US Renal Data System 2021Annual Data Report: Epidemiology of KidneyDisease in the United States. American Journal ofKidney Diseases, Volume 79, Issue 4, A8 - A12

  2. Malyszko J, Oberbauer R, Watschinger B. Anemiaand erythrocytosis in patients after kidneytransplantation. Transpl Int. 2012 Oct;25(10):1013-23. doi: 10.1111/j.1432-2277.2012.01513.x. Epub2012 Jun 21. PMID: 22716097.

  3. Chadban SJ, Baines L, Polkinghorne K, et al. Anemiaafter kidney transplantation is not completelyexplained by reduced kidney function. Am J KidneyDis. 2007 Feb;49(2):301-9. doi: 10.1053/j.ajkd.2006.11.034. Erratum in: Am J Kidney Dis.2009 Dec;54(6):1192-3. PMID: 17261433.

  4. Kasiske BL, Vazquez MA, Harmon WE, et al.;American Society of Transplantation.Recommendations for the outpatient surveillance ofrenal transplant recipients. J Am Soc Nephrol.2000 Oct;11 Suppl 15:S1–86. [PubMed] 1046-6673.

  5. Zheng S, Coyne DW, Joist H, et al. Iron deficiencyanemia and iron losses after renal transplantation.Transpl Int. 2009 Apr;22(4):434–40. https://doi.org/10.1111/j.1432-2277.2008.00814.x [PubMed]0934-0874.

  6. Eisenga M, Minović I, Berger SP, et al. Iron deficiency,anemia, and mortality in renal transplant recipients.Transpl Int. 2016 Nov;29(11):1176–83. https://doi.org/10.1111/tri.12821 [PubMed] 0934-0874.

  7. Schechter A, Gafter-Gvili A, Shepshelovich D, etal. Post transplantation anemia: causes, severity andtheir association with graft and patient survival. ASNKidney Week 2018.

  8. Jeong, J. C. et al. Characteristics of anemia and irondefciency afer kidney transplant. Transplant. Proc.51, 1406–1409. https://doi.org/10.1016/j.transproceed.2019.01.140 (2019).

  9. Malyszko, J., Oberbauer, R. & Watschinger, B.Anemia and erythrocytosis in patients afer kidneytransplantation. Transplant. Int. 25, 1013–1023.

  10. Colucci, S. et al. Te immunophilin FKBP12 inhibitshepcidin expression by binding the BMP type Ireceptor ALK2 in hepatocytes. Blood 130, 2111–2120. https://doi.org/10.1182/blood-2017-04-780692(2017).

  11. Ray PD, et al. Reactive oxygen species (ROS)homeostasiss and redox regulation in cellularsignaling. Cell. Signal. 2012;24:981–990. doi:10.1016/j.cellsig.2012.01.008.

  12. Mehta, R. C. et al. Iron status, fbroblast growthfactor 23 and cardiovascular and kidney outcomes inchronic kidney disease. Kidney Int. 100, 1292–1302.https://doi.org/10.1016/j.kint.2021.07.013 (2021).

  13. Naito, Y. et al. Association between renal ironaccumulation and renal interstitial fbrosis in a ratmodel of chronic kidney disease. Hypertens. Res. 38,463–470. https://doi.org/10.1038/hr.2015.14 (2015).

  14. Ikeda, Y. et al. Dietary iron restriction alleviatesrenal tubulointerstitial injury induced by proteinoverload in mice. Sci. Rep. 7, 10621. https://doi.org/10.1038/s41598-017-11089-0 (2017).

  15. Winkelmayer, W. C., Lorenz, M., Kramar, R., et al.Percentage of hypochromic red blood cells is anindependent risk factor for mortality in kidneytransplant recipients. Am. J. Transplant. 4, 2075–2081. https://doi.org/10.1046/j. 1600-6143.2004.00604.x(2004).

  16. Vaugier, C. et al. Serum iron protects from renalpostischemic injury. J. Am. Soc. Nephrol. 28, 3605–3615. https://doi.org/10.1681/ asn.2016080926 (2017).

  17. Kim HJ, Han R, Kang KP, et al. Impact of ironstatus on kidney outcomes in kidney transplantrecipients. Sci Rep. 2023 Jan 17;13(1):861. doi:10.1038/s41598-023-28125-x. PMID: 36650247;PMCID: PMC9845230.

  18. Bonomini M, Di Liberato L, Sirolli V. TreatmentOptions for Anemia in Kidney Transplant Patients: AReview. Kidney Med. 2023 May 27;5(8):100681.doi: 10.1016/j.xkme.2023.100681. PMID: 37415623;PMCID: PMC10320602.

  19. Gafter-Gvili A, Gafter U. PosttransplantationAnemia in Kidney Transplant Recipients. ActaHaematol. 2019;142(1):37-43. doi: 10.1159/000496140.Epub 2019 Apr 10. PMID: 30970356.

  20. Molnar MZ, Czira M, Ambrus C, et al. Anemia isassociated with mortality in kidney-transplantedpatients-a prospective cohort study. Am J Transplant2007;7:818-24.

  21. Kamar N, Rostaing L, Ignace S, Villar E. Impact ofpost- transplant anemia on patient and graft survivalrates after kid- ney transplantation: a meta-analysis.Clin Transplant. 2011;26: 461-469. doi:10.1111/j.1399-0012.2011.01545.x.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Nefrol Dial Traspl. 2025;45